Spanish Red Biotech Pipeline

Gilead Sciences

Cilofexor / firsocostat / semaglutide combination

Type: Biodrugs/ Drugs
Therapeutic area: Others
Indication: Nonalcoholic steatohepatitis
Phase: 2Phase II in Spain, 1Phase I in Spain